Literature DB >> 1400472

The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils.

S C Afford1, J Pongracz, R A Stockley, J Crocker, D Burnett.   

Abstract

Apoptosis of neutrophils at sites of inflammation in vivo is thought to lead to their recognition and safe elimination by macrophages. Little is known, however, about the regulation of apoptosis in myeloid cells. We report here that the human promonocytic leukemic cell line, U937, and mature human neutrophils can be induced to become apoptotic when cultured with interleukin-6. Apoptosis of U937 cells, assessed morphologically and by the presence of DNA fragmentation, was increased significantly in a dose-dependent fashion by concentrations of 0.5-100 ng/ml interleukin-6. Apoptosis of U937 cells was evident after 48 h of incubation with 20 ng/ml interleukin-6, and the effect was eliminated by adsorption of interleukin-6 with a specific monoclonal antibody. Apoptosis was not evident in the presence of the differentiating agent phorbol 12-myristate 13 acetate; the induction of apoptosis in U937 cells was not therefore a consequence of differentiation. Apoptosis of mature neutrophils was enhanced after 24 h in culture with interleukin-6. Interleukin-6 might be an important factor in the normal resolution of inflammation through the induction of apoptosis of neutrophils.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400472

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation.

Authors:  David J Radford; Keqing Wang; Joanne C McNelis; Angela E Taylor; Georg Hechenberger; Johann Hofmann; Hema Chahal; Wiebke Arlt; Janet M Lord
Journal:  Mol Endocrinol       Date:  2010-02-19

2.  Virus-infected alveolar epithelial cells direct neutrophil chemotaxis and inhibit their apoptosis.

Authors:  Joanna P Rzepka; Anoria K Haick; Tanya A Miura
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-03       Impact factor: 6.914

3.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

4.  Interaction with an endothelial lumen increases neutrophil lifetime and motility in response to P aeruginosa.

Authors:  Laurel E Hind; Patrick N Ingram; David J Beebe; Anna Huttenlocher
Journal:  Blood       Date:  2018-08-24       Impact factor: 22.113

5.  Prevention of neutrophil apoptosis by monosodium urate crystals.

Authors:  T Akahoshi; T Nagaoka; R Namai; N Sekiyama; H Kondo
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

Review 6.  Lung infections. 1. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection.

Authors:  R A Stockley
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

7.  Human blood and synovial fluid neutrophils cultured in vitro undergo programmed cell death which is promoted by the addition of synovial fluid.

Authors:  A L Bell; M K Magill; R McKane; A E Irvine
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

8.  Disentangling the effects of tocilizumab on neutrophil survival and function.

Authors:  Timo Gaber; Martin Hahne; Cindy Strehl; Paula Hoff; Yvonne Dörffel; Eugen Feist; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 9.  IL-6 signalling pathways and the development of type 2 diabetes.

Authors:  Mohamad Akbari; Vahideh Hassan-Zadeh
Journal:  Inflammopharmacology       Date:  2018-03-05       Impact factor: 4.473

10.  Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid.

Authors:  S H Wong; N Francis; H Chahal; K Raza; M Salmon; D Scheel-Toellner; J M Lord
Journal:  Rheumatology (Oxford)       Date:  2008-11-23       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.